A new study by the group of US researchers on breast cancer has revealed that more than half of the patients who have early stages of this cancer leave the full prescribed course of hormone therapy.
In this study the automated pharmacy records of 8,769 women were analyzed, most of them were those who were having type 1, 2 or 3 hormone sensitive breast cancer and it was found out that each woman filled at least one prescription of hormone therapy each year.
While discussing about the study the leading author of the study Dr. Dawn Hershman, an associate professor of medicine and epidemiology at Columbia University Medical Center, said in a news release from the Journal of Clinical Oncology said that “Physicians are often unaware of patient compliance, and this is becoming an increasingly important issue in cancer” and further “It’s very disturbing that patients under 40 had the highest discontinuation rates because those patients have the longest life expectancy”.
The therapies for the treatment of cancer are thus causing illness in ladies and because of that they prefer to leave the treatment in the half or quarter stages and this problem can only be caused if some more consideration is given to those treatments.